Centene Corporation (CNC) Fair Value 2026

CNC · Healthcare Plans ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.4 /10

32 fundamental signals · 3 models active

Value Trap Risk

SAFE (13/100)

Quick Summary — As of 2026-08-27, Centene Corporation (CNC) trades at $65.33, versus a $135.02 median fair value across its 3 active models — 106.7% above the current price. QOC: 7.4/10. Value Trap Risk: 13/100 (SAFE). 3/13 models active.

Key Facts

Ticker
CNC
Price
$65.33
Quality Score
7.4/10
Value Trap Risk
13/100
Models Active
3/13
Last Updated
Strength: FTNN Topology suggests +230.5% upside with 10% confidence
Risk: Limited model coverage (3/13) may reduce confidence

Is Centene Corporation (CNC) Undervalued or Overvalued in 2026?

According to CirclFi’s 3-model valuation engine, Centene Corporation (CNC) appears undervalued as of : the median of 3 independent fair value estimates is $135.02, 106.7% above the current price of $65.33. Estimates range from $55.65 to $215.90. CNC scores 7.4/10 on fundamental quality and 13/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. CNC’s +106.7% gap is wider than that market norm. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Centene Corporation Stock in 2026? →

What Fair Value Does Each Model Give CNC?

3 Intrinsic Value Models vs. Current Price ($65.33)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
$55.65 -14.8%
Relative · Medium Conviction
$135.02 +106.7%
Relative · Low Conviction
$215.90 +230.5%

All Models Active

All 3 models are displayed above.

What Is CNC's Fair Value Range?

Spread across 3 independent models · $55.65 to $215.90

CirclFi's 3 active models place Centene Corporation (CNC) between $55.65 and $215.90 per share, a spread of 119% of the median. The median of that range — $135.02 — is the fair value CirclFi publishes for CNC, against a current price of $65.33.

Low · EPVHigh · FTNN
$55.65median $135.02$215.90
Where the range comes from
Most bearish modelEarnings Power Value (EPV)$55.65
Most bullish modelFTNN Topology$215.90
Model agreement2 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for CNC. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on CNC, not a CirclFi price target. How each model works →

What Is Centene Corporation (CNC) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Centene Corporation's intrinsic value is estimated at $135.02, suggesting a +106.7% median upside from the current price of $65.33. While 2 models see room for appreciation, model agreement is not unanimous as 1 model flags potential overvaluation. Model dispersion is worth noting: FTNN targets $215.90 (+230.5%), versus EPV at $55.65 (-14.8%). This +245.3% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About CNC?

3 of 13 models are currently active for CNC. Of these, 2 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for CNC is $135.02 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does CNC Rank in Healthcare Plans?

Among 12 Healthcare Plans stocks, CNC ranks #8 by Quality of Company score. CirclFi's QOC score of 7.4/10 evaluates 32 fundamental signals. A score of 7.4 indicates above-average quality.

The Healthcare Plans sector introduces analytical considerations specific to biopharma enterprise businesses. For Centene Corporation, metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.

Is CNC a Value Trap?

CirclFi's Value Trap algorithm assigns CNC a score of 13/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

3 of 13 models are active for Centene Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Centene Corporation earns a quality score of 7.4/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +245.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CNC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CNC's 3 active models, average confidence is 44%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Centene Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Healthcare Plans Stocks Should You Also Analyze?

11 related Healthcare Plans stocks with 13-model coverage

Read investment analysis: PGNY · PFHO · ELV · UNH · CI · MOH · HUM · ALHC · OSCR · CLOV · MRAI

Which Other Stocks Have a Similar Quality Score to CNC?

7 companies across all industries closest to CNC’s Quality of Company score of 7.4/10.

Read investment analysis: CPT · PFG · GS · NNI · FROG · SBUX · NVDA

What Else Do Investors Ask About Centene Corporation’s Valuation?

What is Centene Corporation's intrinsic value in 2026?

CirclFi puts Centene Corporation (CNC)'s intrinsic value at $135.02 — the median of 3 independent model estimates as of 2026-08-27, ranging from $55.65 to $215.90. The Quality of Company score is 7.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CNC overvalued or undervalued right now?

At $65.33, 2 of 3 active models suggest CNC may be undervalued, while 1 indicate potential overvaluation. The median of all 3 fair value estimates is $135.02, 106.7% above the current price of $65.33 — a consensus view that CNC is undervalued. The assessment depends on which methodology best fits Centene Corporation's business model in Healthcare Plans.

What does a Quality of Company score of 7.4 mean for CNC?

Centene Corporation's QOC of 7.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on CNC?

CirclFi analyzes CNC with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 3 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on CNC?

Of the 3 models currently active on CNC, FTNN Topology is the most bullish at $215.90 per share, and Earnings Power Value (EPV) is the most bearish at $55.65. CirclFi's published fair value for CNC is the median of that range, $135.02, not either extreme. The gap between the two ends equals 119% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is CNC a value trap in 2026?

Centene Corporation's Value Trap score is 13/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 3-model valuation engine, Centene Corporation (CNC) has a median fair value of $135.02 — 106.7% above the current price of $65.33 — as of 2026-08-27.” Source: circlfi.com/stock/CNC/ · Methodology
Primary sources for this CNC valuation
  • Financial statements: Centene Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001071739) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CNC as of ; valuations recomputed .